Get started
Author

Manuela Terrinoni

Observed name: Terrinoni, Manuela
ORCID: 0000-0002-2664-3210
Observed ORCID: 0000-0002-2664-3210
OpenAlex ID: A5027780128
Cholera Toxin, and the Related Nontoxic Adjuvants mmCT and dmLT, Promote Human Th17 Responses via Cyclic AMP–Protein Kinase A and Inflammasome-Dependent IL-1 Signaling
2015 · Maximilian Larena, Jan Holmgren, et al. · The Journal of Immunology · 74
Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae
2016 · Michael Lebens, Manuela Terrinoni, et al. · Vaccine · 43
Deficiency in Calcium-Binding Protein S100A4 Impairs the Adjuvant Action of Cholera Toxin
2017 · Jia-Bin Sun, Jan Holmgren, et al. · Frontiers in Immunology · 21
PDF
Generation of Human Single-chain Antibody to the CD99 Cell Surface Determinant Specifically Recognizing Ewing’s Sarcoma Tumor Cells
2013 · Mara Gellini, Alessandro Ascione, et al. · Current Pharmaceutical Biotechnology · 21
Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NFκB Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative mmCT
2019 · Manuela Terrinoni, Jan Holmgren, et al. · Frontiers in Immunology · 14
PDF
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity
2019 · Manuela Terrinoni, Jan Holmgren, et al. · Scientific Reports · 11
PDF
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
2021 · Ingrid Yao Mattisson, Sara Rattik, et al. · Vascular Pharmacology · 9
Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc
2021 · Dani Zalem, Martin Juhás, et al. · Glycobiology · 8
PDF
A Novel Nonantibiotic, lgt -Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae
2017 · Manuela Terrinoni, Stefan L. Nordqvist, et al. · Applied and Environmental Microbiology · 8
PDF
A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccine
2023 · Manuela Terrinoni, Stefan L. Nordqvist, et al. · Vaccine · 6
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
2018 · Sara Rattik, Polyxeni T. Mantani, et al. · Vascular Pharmacology · 6
Potential for a Combined Oral Inactivated Whole-Cell Vaccine Against ETEC and Shigella: Preclinical Studies Supporting Feasibility
2025 · Manuela Terrinoni, Jan Holmgren, et al. · Vaccines · 4
PDF
Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
2025 · Geert V. T. Roozen, Nsofwa Sukwa, et al. · Vaccines · 3
PDF
Heterologous prime-boost immunization combining parenteral and mucosal routes with different adjuvants mounts long-lived CD4+ T cell responses in lungs
2025 · Ranmali Kavishna, Thorunn Asta Olafsdottir, et al. · Frontiers in Immunology · 2
PDF
Co-administration of oral killed whole-cell recombinant cholera toxin B-subunit vaccine (WC-rCTB) and live Salmonella Typhi Ty21a vaccine: a prospective randomized open-label trial
2026 · Marianna Riekkinen, Manuela Terrinoni, et al. · Journal of Travel Medicine · 1
Development of DuoChol, a Thermostable Inactivated Whole-Cell/B-Subunit Oral Cholera Vaccine in Enteric Capsule
2026 · Manuela Terrinoni, Michael R. Lebens, et al. · Vaccines
Novel approaches to mucosal vaccine development Strategies in vaccine antigen production, construction of a novel mucosal adjuvant and studies of its mode of action
2019 · Manuela Terrinoni · Gothenburg University Publications Electronic Archive (Gothenburg University)
Works count: 18
Citation count: 231
H-index: 8
I10-index: 6
Year
Topic
Type